Compare OSW & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OSW | LMAT |
|---|---|---|
| Founded | 2017 | 1983 |
| Country | Bahamas | United States |
| Employees | N/A | N/A |
| Industry | Hotels/Resorts | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.1B |
| IPO Year | 2019 | 2006 |
| Metric | OSW | LMAT |
|---|---|---|
| Price | $26.60 | $105.78 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 5 |
| Target Price | $27.00 | ★ $105.80 |
| AVG Volume (30 Days) | ★ 821.4K | 250.9K |
| Earning Date | 04-29-2026 | 05-05-2026 |
| Dividend Yield | 0.81% | ★ 0.93% |
| EPS Growth | N/A | ★ 30.57 |
| EPS | 0.44 | ★ 0.68 |
| Revenue | ★ $961,001,000.00 | $249,602,000.00 |
| Revenue This Year | $7.49 | $14.21 |
| Revenue Next Year | $8.52 | $8.88 |
| P/E Ratio | ★ $59.91 | $152.37 |
| Revenue Growth | 7.37 | ★ 13.53 |
| 52 Week Low | $19.06 | $79.40 |
| 52 Week High | $29.25 | $118.01 |
| Indicator | OSW | LMAT |
|---|---|---|
| Relative Strength Index (RSI) | N/A | N/A |
| Support Level | N/A | N/A |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 0.00 | 0.00 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 0.00 | 0.00 |
OneSpaWorld Holdings Ltd is an operator of health and wellness centers onboard cruise ships and an operator of health and wellness centers at destination resorts all over the world. It offers a suite of premium health, fitness, beauty, and wellness services and products. The services provided by the company include body, salon, and skin care services and products, fitness classes and personal fitness training and pain management, detoxifying programs, and comprehensive body composition analyses among others. The company has only one single segment of Maritime and Destination Resorts.
LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.